“GLP-1 Therapies Enter the CKM Guideline For the first time, GLP-1-based therapy is recommended to reduce cardiac events” (2026) Diabzen, 4(18), pp. 36–37. Available at: https://thediabzen.com/index.php/d/article/view/61 (Accessed: 28 July 2026).